TerrAscend Corp. (OTCMKTS:TSNDF) Short Interest Up 90.1% in April

Posted by Brenda Bartman on May 19th, 2026

TerrAscend Corp. (OTCMKTS:TSNDF – Get Free Report) saw a significant increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,311,616 shares, an increase of 90.1% from the April 15th total of 690,140 shares. Approximately 0.6% of the company’s shares are sold short. Based on an average daily volume of 1,739,639 shares, the short-interest ratio is currently 0.8 days.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of TerrAscend from a “strong sell” rating to a “hold” rating in a research note on Tuesday, February 10th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, TerrAscend currently has a consensus rating of “Buy”.

Check Out Our Latest Stock Analysis on TSNDF

TerrAscend Stock Performance

Shares of TSNDF stock opened at $0.67 on Tuesday. The company’s fifty day simple moving average is $0.68 and its 200-day simple moving average is $0.67. TerrAscend has a 52 week low of $0.23 and a 52 week high of $1.45. The company has a current ratio of 1.51, a quick ratio of 0.98 and a debt-to-equity ratio of 2.66. The company has a market cap of $205.47 million, a PE ratio of -6.66 and a beta of 1.42.

TerrAscend (OTCMKTS:TSNDF – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). TerrAscend had a negative net margin of 44.87% and a negative return on equity of 24.69%. The business had revenue of $65.54 million during the quarter, compared to analysts’ expectations of $65.25 million. As a group, equities research analysts anticipate that TerrAscend will post -0.08 EPS for the current year.

TerrAscend Company Profile

(Get Free Report)

TerrAscend is a vertically integrated cannabis company that operates across cultivation, processing and retailing in North America. The company’s business model spans seed-to-sale activities, enabling it to manage quality control, production efficiency and product innovation from its growing facilities through to its distribution networks. TerrAscend serves both adult-use and medical cannabis markets, offering a full suite of cannabis derivatives including dried flower, concentrates, vapes, edibles, tinctures and topicals.

Geographically, TerrAscend maintains operations in key regulated markets.